01. 27. 2020

Less artificial…more intelligence

In the industry of clinical research, we are accustomed to working with conservative companies that make decisions slowly. Look at the adoption of EDC – over how many decades now? Understandable, at least to a point.

Read more
09. 24. 2019

Filling the tech gap in metastatic breast cancer clinical trials

According to the American Cancer Society (ACS), a woman living in the United States has a 1 in 8 chance of developing breast cancer, the second-leading cause of cancer death in women (behind only lung cancer).

Read more
05. 28. 2019

Site, investigator, or investigator site?

The life sciences industry is riddled with casually used terms, acronyms and phrases which are often used out of context or defined differently among companies or individuals.

Read more
03. 15. 2019

Kols: an endangered buzzword

The term, “key opinion leader” (supported by its well-known acronym KOL) is one of the industry’s most common buzzwords, and for good reason.

Read more